Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes
Lin Zhang, Yanjin Hu, Yu An, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 18

Showing 18 citing articles:

The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus
Duygu Ağagündüz, Mehmet Arif İçer, Özge Yeşildemir, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 47
Lipid remodeling of adipose tissue in metabolic health and disease
Yoon Keun Cho, S. Lee, J.R. Lee, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 9, pp. 1955-1973
Open Access | Times Cited: 17
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
Damien Denimal, Victoria Bergas, Jean-Paul Pais-de-Barros, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease
Cheng Zhu, Qian Huai, Xu Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 311-330
Open Access | Times Cited: 23
Chewing the fat: How lipidomics is changing our understanding of human health and disease in 2022
Caroline Géhin, Stephen J. Fowler, Drupad K. Trivedi
Analytical Science Advances (2023) Vol. 4, Iss. 3-4, pp. 104-131
Open Access | Times Cited: 10
Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes
Damien Denimal, Laurence Duvillard, Sarah Béland-Bonenfant, et al.
Diabetes & Metabolism (2024) Vol. 50, Iss. 4, pp. 101542-101542
Open Access | Times Cited: 3
Lipid Metabolism in MASLD and MASH: from mechanism to the clinic
Fabrizia Carli, Giuseppe Della Pepa, Silvia Sabatini, et al.
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101185-101185
Open Access | Times Cited: 3
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
Asger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer
Furong Yan, Chanjuan Liu, Dongli Song, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 2
Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
Damien Denimal, Sarah Béland-Bonenfant, Jean-Paul Pais-de-Barros, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Integration of systematic review, lipidomics with experiment verification reveals abnormal sphingolipids facilitate diabetic retinopathy by inducing oxidative stress on RMECs
Zhenshuang Yuan, Yue Tian, Cong Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2023) Vol. 1868, Iss. 11, pp. 159382-159382
Closed Access | Times Cited: 4
Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance
Georg Peschel, Sabrina Krautbauer, Kilian Weigand, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1198-1198
Open Access | Times Cited: 1
GLP-1 receptor agonist treatment improved fasting and postprandial lipidomic profile independently of diabetes and weight loss
Giuseppe Della Pepa, Bárbara G. Patrício, Fabrizia Carli, et al.
Diabetes (2024) Vol. 73, Iss. 10, pp. 1605-1614
Closed Access | Times Cited: 1
Analysis of Methylome, Transcriptome, and Lipid Metabolites to Understand the Molecular Abnormalities in Polycystic Ovary Syndrome
Fei Zhang, Yicen Ding, Bohan Zhang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 2745-2763
Open Access | Times Cited: 3
Ethnic Disparities in Lipid Metabolism and Clinical Outcomes between Dutch South Asians and Dutch White Caucasians with Type 2 Diabetes Mellitus
Lushun Yuan, Aswin Verhoeven, Niek Blomberg, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 33-33
Open Access
Investigating a New Way to Assess Metabolic Risk in Pregnant Females with Prior RYGB Surgery
Teresa Gisinger, Birgit Reiter, Karin Preindl, et al.
Nutrients (2024) Vol. 16, Iss. 16, pp. 2704-2704
Open Access
The signature of serum lipids remodeling in recent-onset type 2 diabetes mellitus treated with dulaglutide and liraglutide
Juan Du, Xiaoxu Ge, Wenyi Li, et al.
International Journal of Diabetes in Developing Countries (2024)
Closed Access
Gender-Specific Differences in Serum Sphingomyelin Species in Patients with Hepatitis C Virus Infection—Sphingomyelin Species Are Related to the Model of End-Stage Liver Disease (MELD) Score in Male Patients
Georg Peschel, Kilian Weigand, Jonathan Grimm, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8402-8402
Open Access | Times Cited: 1
Page 1

Scroll to top